Really appreciate your FCF and debt analysis, Andrew. Thanks!
Bell Potter is often overoptimistic in its forecasts of growth, dividends, or some combination. Still, I recall a HC post pointing out that at least one substantial holder insto is pushing DNA to introduce a divvie soon. Also, the board has twice stated since Dec15 that it is investigating cap mgt activity (i.e. divvie and/or buyback). Meanwhile, I penned in 1cps dividend for 1H17 (and none of 2H16), more as a hope than expectation.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $53.12M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.3¢ | 4.3¢ | $18.87K | 438.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 2780045 | 4.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 2773999 | 7 |
View Market Depth
| Last trade - 15.58pm 18/07/2025 (20 minute delay) ? |
| DNA (ASX) Chart |